Edgepark adds new automated insulin delivery device to portfolio
By HME News Staff
Updated 8:38 AM CST, Wed February 14, 2024
TWINSBURG, Ohio – Edgepark is now offering the newly launched Beta Bionics iLet Bionic Pancreas fully automated insulin delivery (AID) system as part of its comprehensive diabetes management solution portfolio. The iLet does not require carbohydrate counting for carb-aware users and fully automates 100% of insulin doses. Designed for anyone 6 years of age and older living with Type 1 diabetes, it eliminates the traditional manual work previously involved with using an insulin pump. “It’s deeply critical that our customers have access to the latest innovations that remove complexities to care, especially when managing a disease as complicated as Type 1 diabetes,” said Anthony Alvarez, senior vice president and general manager, Edgepark. “Edgepark is thrilled to offer the iLet as a first-of-its-kind device that uses automation to make diabetes simpler to navigate.” The iLet automatically delivers basal, correction and meal doses based on a user’s own real-time health data, providing more freedom to the user in their daily life. The system also learns a user’s personal trends to adjust insulin, including how many carbs are normally consumed during meals, corrections needed and more.
Comments